Visibility: Ongoing

  • Arnasa Copd

    12 August 2024
    Evaluating novel treatments for chronic obstructive pulmonary disease to enhance breathing and overall lung function.
  • Pilaster Copd

    12 August 2024
    Investigating innovative therapies for chronic obstructive pulmonary disease to improve patient outcomes and quality of life.
  • Gerd

    12 August 2024
    Evaluating new methods to alleviate symptoms of gastroesophageal reflux disease (GERD), a chronic digestive disorder.
  • Elevate Ulcerative Colitis

    12 August 2024
    Assessing innovative therapies for ulcerative colitis to improve patient care and disease management.
  • Incyte 211 Liver

    12 August 2024
    Evaluating a new treatment approach for hepatocellular cancer, the most common type of primary liver cancer.